Literature DB >> 19655376

Surface activity of a monoclonal antibody.

Hanns-Christian Mahler1, Frank Senner, Karsten Maeder, Robert Mueller.   

Abstract

The development of high concentration antibody formulations presents a major challenge for the formulation scientist, as physical characteristics and stability behavior change compared to low concentration protein formulations. The aim of this study was to investigate the potential correlation between surface activity and shaking stress stability of a model antibody-polysorbate 20 formulation. The surface activities of pure antibody and polysorbate 20 were compared, followed by a study on the influence of a model antibody on the apparent critical micelle concentration (CMC) of polysorbate 20 over a protein concentration range from 10 to 150 mg/mL. In a shaking stress experiment, the stability of 10, 75, and 150 mg/mL antibody formulations was investigated containing different concentrations of polysorbate 20, both below and above the CMC. The antibody increased significantly the apparent CMC of antibody-polysorbate 20 mixtures in comparison to the protein-free buffer. However, the concentration of polysorbate required for stabilization of the model antibody in a shaking stress experiment did not show dependence on the CMC. A polysorbate 20 level of 0.005% was found sufficient to stabilize both at low and high antibody concentration against antibody aggregation and precipitation. 2009 Wiley-Liss, Inc. and the American Pharmacists Association

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19655376     DOI: 10.1002/jps.21776

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  10 in total

1.  The role of polysorbate 80 and HPβCD at the air-water interface of IgG solutions.

Authors:  Tim Serno; Elisabeth Härtl; Ahmed Besheer; Reinhard Miller; Gerhard Winter
Journal:  Pharm Res       Date:  2012-08-22       Impact factor: 4.200

2.  Effect of Polysorbate 20 and Polysorbate 80 on the Higher-Order Structure of a Monoclonal Antibody and Its Fab and Fc Fragments Probed Using 2D Nuclear Magnetic Resonance Spectroscopy.

Authors:  Surinder M Singh; Swati Bandi; David N M Jones; Krishna M G Mallela
Journal:  J Pharm Sci       Date:  2017-08-24       Impact factor: 3.534

3.  The degradation of polysorbates 20 and 80 and its potential impact on the stability of biotherapeutics.

Authors:  Ravuri S K Kishore; Sylvia Kiese; Stefan Fischer; Astrid Pappenberger; Ulla Grauschopf; Hanns-Christian Mahler
Journal:  Pharm Res       Date:  2011-03-03       Impact factor: 4.200

4.  Differential Surface Adsorption Phenomena for Conventional and Novel Surfactants Correlates with Changes in Interfacial mAb Stabilization.

Authors:  Ankit D Kanthe; Miriam R Carnovale; Joshua S Katz; Susan Jordan; Mary E Krause; Songyan Zheng; Andrew Ilott; William Ying; Wei Bu; Mrinal K Bera; Binhua Lin; Charles Maldarelli; Raymond S Tu
Journal:  Mol Pharm       Date:  2022-07-26       Impact factor: 5.364

5.  Disruption of Escherichia coli amyloid-integrated biofilm formation at the air-liquid interface by a polysorbate surfactant.

Authors:  Cynthia Wu; Ji Youn Lim; Gerald G Fuller; Lynette Cegelski
Journal:  Langmuir       Date:  2013-01-09       Impact factor: 3.882

6.  Knockout of a difficult-to-remove CHO host cell protein, lipoprotein lipase, for improved polysorbate stability in monoclonal antibody formulations.

Authors:  Josephine Chiu; Kristin N Valente; Nicholas E Levy; Lie Min; Abraham M Lenhoff; Kelvin H Lee
Journal:  Biotechnol Bioeng       Date:  2016-12-27       Impact factor: 4.530

7.  The effects of excipients on protein aggregation during agitation: an interfacial shear rheology study.

Authors:  Lu Liu; Wei Qi; Daniel K Schwartz; Theodore W Randolph; John F Carpenter
Journal:  J Pharm Sci       Date:  2013-05-27       Impact factor: 3.534

8.  Surfactant Effects on Particle Generation in Antibody Formulations in Pre-filled Syringes.

Authors:  Alana Gerhardt; Aaron C Mcumber; Bao H Nguyen; Rachael Lewus; Daniel K Schwartz; John F Carpenter; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2015-09-28       Impact factor: 3.534

9.  Characterization of particles in protein solutions: reaching the limits of current technologies.

Authors:  Barthélemy Demeule; Steven Messick; Steven J Shire; Jun Liu
Journal:  AAPS J       Date:  2010-10-16       Impact factor: 4.009

10.  Shocking Data on Parcel Shipments of Protein Solutions.

Authors:  Christine Siska; Paul Harber; Bruce A Kerwin
Journal:  J Pharm Sci       Date:  2019-11-02       Impact factor: 3.534

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.